Embryofetopathy due to oral anticoagulant therapy (Q46697): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/71579696
@@ Property / Canonical URI: https://id.who.int/icd/entity/71579696 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:LD2F.02
@@ Property / CURIE: CID11:LD2F.02 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-LD2F.02
@@ Property / Canary Token: dki-india-LD2F.02 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-13T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-13T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 13 August 2026 / rank @@
+Normal rank
@@ Property / Linked ICD 10 @@
+DAVID EDUARDO CALIL
@@ Property / Linked ICD 10: DAVID EDUARDO CALIL / rank @@
+Normal rank

Latest revision as of 15:28, 13 August 2026

A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia.

Language	Label	Description	Also known as
default for all languages	LD2F.02
English	Embryofetopathy due to oral anticoagulant therapy	A condition caused by exposure of the embryo or fetus to anticoagulants during the antenatal period. This disease may present with optic nerve anomaly, optic atrophy, anomaly of the papilla, blindness, or choanal atresia.